Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.
Open Access
- 1 October 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 135 (4) , 2319-2322
- https://doi.org/10.4049/jimmunol.135.4.2319
Abstract
Synthetic antigens have been shown, in experimental models, to induce protective immunity against a variety of pathogens. These studies have demonstrated that, due to their low immunogenicity, these synthetic antigens required conjugation to carrier molecules. Therefore, the choice of appropriate carriers for human immunization by future synthetic vaccines is a major issue. Tetanus toxoid is generally considered to be an effective potential carrier devoid of side-effects. However, the present study performed in mice with two synthetic vaccine models demonstrates that the immune response against the synthetic epitopes conjugated to tetanus toxoid can be suppressed by pre-existing immunity against this same carrier. Because most humans have been exposed to this antigen, this effect may have important implications for the development of synthetic vaccines.This publication has 13 references indexed in Scilit:
- Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvantBiochemical and Biophysical Research Communications, 1983
- Immunological castration of male mice by a totally synthetic vaccine administered in saline.Proceedings of the National Academy of Sciences, 1982
- Successful immunization with a totally synthetic diphtheria vaccine.Proceedings of the National Academy of Sciences, 1982
- Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memoryThe Journal of Experimental Medicine, 1982
- Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responsesThe Journal of Experimental Medicine, 1982
- Active antitoxic immunization by a diphtheria toxin synthetic oligopeptideNature, 1981
- Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.Proceedings of the National Academy of Sciences, 1980
- Repeating covalent structure of streptococcal M protein.Proceedings of the National Academy of Sciences, 1978
- Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigenThe Journal of Experimental Medicine, 1977
- Coexistence of Helper and Suppressor Activities in Carrier-Primed Spleen CellsThe Journal of Immunology, 1976